REFERENCES
- Afar, D. E. H., A. Goga, J. McLaughlin, O. N. Witte, C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424–426.
- Annamalai, A. E., and R. F. Colman. 1981. Reaction of the adenine nucleotide analogue 5′-p-fluorosulfonylbenzoyl adenosine at distinct tyrosine and cysteine residues of rabbit muscle pyruvate kinase. J. Biol. Chem. 256:10276–10283.
- Boyle, W. J., P. Van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
- Campbell, M., W. Li, and R. B. Arlinghaus. 1990. P210 BCR-ABL is com- plexed to P160 BCR and ph-P53 proteins in K562 cells. Oncogene 5:773–776.
- Campbell, M. L., and R. B. Arlinghaus. 1991. Current status of the BCR gene and its involvement with human leukemia. Adv. Cancer Res. 57:227–256.
- Chackalaparampil, I., and D. Shalloway. 1988. Altered phosphorylation and activation of pp60c-src during fibroblast mitosis. Cell 52:801–810.
- Daley, G. Q., R. A. van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the P210bcr-abl gene of the Philadelphia chromosome. Science 247:824–830.
- Deng, W. P., and J. A. Nickoloif. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81–88.
- Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature (London) 363:88–92.
- Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukemia in BCR-ABL transgenic mice. Nature (London) 344:251–253.
- Hunter, T., and J. A. Cooper. 1986. Viral oncogenes and tyrosine phosphorylation. Enzymes 17:191–246.
- Hunter, T., and B. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311–1315.
- Kloetzer, W., R. Kurzrock, L. Smith, M. Talpaz, M. Spiller, J. Gutterman, and R. B. Arlinghaus. 1985. The human cellular abl gene product in the chronic myelogenous leukemia. Virology 140:230–238.
- Konopka, J. B., S. M. Watanabe, and O. N. Witte. 1984. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035–1042.
- Li, W., O. Dreazen, W. Kloetzer, R. P. Gale, and R. B. Arlinghaus. 1989. Characterization of bcr gene products in hematopoietic cells. Oncogene 4:127–138.
- Liu, J., M. Campbell, J. G. Guo, D. Lu, Y. M. Xian, B. S. Andersson, and R. B. Arlinghaus. 1993. Bcr-Abl tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8:101–109.
- Lu, D., J. Liu, M. Campbell, J. G. Guo, N. Heisterkamp, J. Groffen, E. Cannani, and R. B. Arlinghaus. 1993. Tyrosine phosphorylation of P160 BCR by P145 c-ABL and P210 BCR-ABL. Blood 82:1257–1260.
- Maru, Y., K. L. Peters, D. E. H. Afar, M. Shibuya, O. N. Witte, and T. E. Smithgall. 1995. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15:835–842.
- Maru, Y., and O. N. Witte. 1991. The BCR gene encodes a novel serine/ threonine kinase activity within a single exon. Cell 67:459–468.
- McWhirter, J. R., and J. Y. J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol. 11:1553–1565.
- Norbury, C., J. Blow, and P. Nurse. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321–3329.
- Pendergast, A. M., M. L. Gishizky, M. H. Havlik, and O. N. Witte. 1993. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence. Mol. Cell. Biol. 13:1728–1736.
- Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB2 adaptor protein. Cell 75:175–185.
- Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. BCR-ABL oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764–773.
- Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature (London) 315:550–554.
- Stam, K., N. Heisterkamp, G. Grosveld, A. de Klein, R. S. Verma, M. Coleman, H. Dosik, and J. Groffen. 1985. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N. Engl. J. Med. 313:1429–1433.
- Stam, K., N. Heisterkamp, F. H. Reynolds, Jr., and J. Groffen. 1987. Evidence that the phi gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol. Cell. Biol. 7:1955–1960.
- Sullivan, S., and T. W. Wong. 1991. A manual sequencing method for identification of phosphorylated amino acids in phosphopeptides. Anal. Bio-chem. 197:65–68.